coronavirus vaccine

Stories 781 - 800 | << Prev   Next >>

Vaccines Progressing Quickly, but Not for Kids

Possible one won't be ready before the start of the 2021 school year

(Newser) - Work on vaccines is speeding along in the US, but one group will likely have a longer wait than everyone else: children. Trials currently underway involve adults only—and it's too dangerous to simply apply those results to kids, explains the New York Times . "Right now I'm...

In Race for Vaccine, a Cold Truth
In Race for
Vaccine, a
Cold Truth
Sep 18, 2020 12:23 PM CDT

In Race for Vaccine, a Cold Truth

There may not be enough freezers icy enough to store the shots

(Newser) - "Do we have enough freezers?" That's a question many may not be pondering now, but it's an important one when it comes to a COVID-19 vaccine, per the Wall Street Journal . That's because the inoculation samples that may soon emerge might need to be stored at...

'I Am a Normal, Un-Brave Person.' And Patient 1133

Want a return to normal? Enroll in a vaccine trial, writes Molly Jong-Fast

(Newser) - "I am a normal, un-brave person. I am also a part of history now," writes Molly Jong-Fast, an editor-at-large for the Daily Beast and "Patient 1133" in Pfizer's coronavirus vaccine trial. In a New York Times op-ed, Jong-Fast describes the pride she felt (well, after the...

Moderna CEO: It Might Be a Year Before You Get a Vaccine

Initial data review expected in November

(Newser) - Moderna plans to seek emergency approval of its coronavirus vaccine candidate once data shows it to be at least 70% effective—but that's not likely to occur before November and perhaps not until mid-2021. That's according to the company's 135-page plan for analyzing trial data, released Thursday....

Trump: CDC Director 'Made a Mistake' on Vaccine Timing

Redfield said masks could be more effective protection than vaccine

(Newser) - Centers for Disease Control and Prevention Director Robert Redfield testified at a Senate hearing Wednesday—and his remarks clashed with some of what President Trump has been saying. Face masks are "the most important public health tool we have" in fighting the pandemic and could even be more effective...

Bill Gates: US Pandemic Response is 'Shocking'

He also doesn't expect a vaccine before Election Day

(Newser) - Bill Gates has some bad news for President Trump, who has suggested that a coronavirus vaccine could be available by Election Day. Gates tells CNBC that he doesn't see it happening. "None of the vaccines are likely to seek approval in the US before the end of October,...

These States Do the Most Vaccinating

Rankings could suggest success or failure in fight against COVID-19

(Newser) - Once an effective COVID-19 vaccine is ready, its success or failure will depend largely on whether most people get it. That answer is in doubt; one poll found that about one-third of Americans would choose to not be vaccinated—despite a long record of lifesaving, money-saving vaccines. The World Health...

Big Vaccine Trial Is Back Despite 'Unwell' Woman

Oxford University's work with AstraZeneca resumes

(Newser) - Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the UK, the AP reports. In a statement, the university said in large trials such as this "it...

China Has Notable New Entry in Race for Vaccine

It's the first nasal spray for COVID to proceed to human trials

(Newser) - About three dozen coronavirus vaccine candidates are in human testing around the world, all of them using the standard approach of a needle to deliver an injection. China, however, has just given approval for the first nasal spray to proceed to human trials, reports Bloomberg . One hope is that a...

If You Get Vaccinated, You Should Collect $1K
If You Get Vaccinated,
You Should Collect $1K
OPINION
Sep 10, 2020 4:37 PM CDT

If You Get Vaccinated, You Should Collect $1K

Economists make the case that the incentive is necessary and a wise COVID investment

(Newser) - An economist is backing a provocative idea on a COVID vaccine: Anyone who gets a shot should receive $1,000 from the government. So argues Harvard's N. Gregory Mankiw in a New York Times op-ed. Mankiw is actually writing in support of a proposal first floated by fellow economist...

After 'Unexplained Illness,' Big Vaccine Trial Pauses

AstraZeneca is working on a vaccine for COVID-19

(Newser) - AstraZeneca's coronavirus vaccine trial is on hold after a participant in a UK study developed what the pharmaceutical company calls "a potentially unexplained illness." The clinical trials of the experimental vaccine have been paused while safety data is reviewed and the illness is investigated, the Wall Street ...

Trump Slams Biden and Harris for &#39;Anti-Vaccine Rhetoric&#39;
New Flashpoint in the
2020 Campaign: COVID Vaccine
the rundown
Sep 8, 2020 6:53 AM CDT

New Flashpoint in the 2020 Campaign: COVID Vaccine

Trump says Biden, Harris must apologize for 'anti-vaccine rhetoric'

(Newser) - President Trump on Monday used the term "anti-vaccine" to describe his Election 2020 opponent and his running mate after they remarked on whether or not they'd get a coronavirus vaccine if one becomes available before the election. Here's what went down, per NBC News and the Hill...

These Americans Will Get a Vaccine First
These Americans Will 
Get a Vaccine First
in case you missed it
Sep 6, 2020 10:10 AM CDT

These Americans Will Get a Vaccine First

In hypothetical plan, CDC lays out guidelines on distribution, to start as early as next month

(Newser) - Public health officials across the country have been told to prepare to distribute a coronavirus vaccine as soon as late October—though the CDC says this is just a hypothetical. In documents sent to health authorities in all states and territories, as well as five major cities (New York, Chicago,...

Outside Analysis Sees Promise, Few Risks in Russian Vaccine

The Lancet publishes data showing antibodies were generated with mostly mild side effects

(Newser) - Experts have been skeptical about Russia's quick approval of a COVID-19 vaccine, but a bit of early validation has arrived. The Lancet published data Friday indicating that subjects given the vaccine developed antibodies to the coronavirus in phases 1 and 2 of testing. Antibody levels were at least what...

US Says It Won't Join Global Vaccine Effort

Critics slam 'go-it-alone approach'

(Newser) - The Trump administration said Tuesday that it will not work with an international cooperative effort to develop and distribute a COVID-19 vaccine because it does not want to be constrained by multilateral groups like the World Health Organization. The decision to go it alone follows the White House’s decision...

Unusual Shortage Could Affect Vaccine Research

US doesn't have enough test monkeys

(Newser) - The US needs a coronavirus vaccine. It also needs monkeys on which to test that vaccine, and that's where we have a problem. As the Atlantic reports, there is a national shortage of "nonhuman primates" used in animal testing, most of which come from China. The country provided...

Country Says It Never OKed Vaccine Given to Chinese Workers

Papua New Guinea bans flight carrying mining workers from China

(Newser) - Papua New Guinea prevented the arrival of a flight carrying Chinese workers after a Chinese mining company claimed to have immunized employees against COVID-19 in an apparent vaccination trial, authorities said Friday. The Pacific nation's pandemic response controller, David Manning, banned COVID-19 vaccine testing or trials after Ramu NiCo...

Andrew Lloyd Webber Puts His Money Where His Mouth Is

Says he would do 'anything' to reopen theaters, steps up for vaccine trial

(Newser) - Andrew Lloyd Webber is anxious to get audiences back to the theater, which is why he's now taking part in a coronavirus vaccine trial from Oxford University and pharmaceutical company AstraZeneca. "I am excited that tomorrow I am going to be vaccinated for the Oxford Covid 19 trial,...

Fauci: Russia Vaccine Risks 'Hurting a Lot of People'

He says he has serious doubts about its safety

(Newser) - Russia claims to have won the COVID-19 vaccine race —but experts, including Dr. Anthony Fauci, have their doubts about whether the vaccine will be safe or effective. In a National Geographic panel discussion set to air in full Thursday, Fauci told moderator Deborah Roberts that he has deep misgivings...

Scientists Sound Alarm Over Russia's Race for Vaccine

It may be unsafe as well as ineffective, they warn

(Newser) - Russia is boasting that it is about to become the first country to approve a COVID-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials—and scientists worldwide are sounding the alarm that the headlong rush could backfire. Moscow sees a...

Stories 781 - 800 | << Prev   Next >>